About Carelon Research
Who we are
HealthCore is now Carelon Research. As a member of the Carelon family of companies under Elevance Health, we have an opportunity to amplify the impact of research as a critical component and driver of Carelon’s goal of better solving complex challenges in healthcare. We’re also uniquely positioned to provide evidence-based insights back to Elevance Health through innovative research solutions and multi-stakeholder collaborations.
We’re committed to supporting the need for evidence generation and research collaboration in the marketplace, and delivering the expertise, unparalleled data, relationships, and evidence-generation capabilities long valued by our partners and clients in life sciences, government, and academia.
We can determine the right questions to ask, design studies to provide comprehensive answers, and translate and deliver meaningful results necessary for impactful decisions across the healthcare continuum – from treatment development through care delivery and policy.
What we do
At Carelon Research, we help improve the future of healthcare with trusted insights powered by evidence. As part of Elevance Health, we are the direct recipients of our data assets, curated in the Healthcare Integrated Research Database (HIRD®). Our ability to link data using deterministic matching enables our teams to design, conduct, and analyze complex data in ways that others cannot.
We can determine the right questions to ask, design studies to provide comprehensive answers, and translate and deliver meaningful results necessary for impactful decisions across the healthcare continuum – from treatment development through care delivery and policy.
What we offer
- Health economics & outcomes research: Identifies the real-world value of biomedical products and leverages those insights to advance actionable information for stakeholders.
- Safety & epidemiology research: Uncovers vital evidence on the use, safety, and efficacy of biomedical products in large, real-world patient populations.
- Clinical research: Designs and executes clinical trials from start-up to closeout to drive needed therapies and meaningful outcomes.
- Patient-centered research: Engages the voices of patients in research to make therapies and programs more real-world-ready and relevant.
Who we work with
Carelon Research partners with life sciences companies, government agencies, academic institutions, and other key healthcare stakeholders who rely on evidence to guide decisions. We work collaboratively to help provide answers to improve outcomes, lives, and communities.
Our story
Carelon Research was founded in 1996 on the need for better evidence in healthcare decision making. Long before real-world evidence was part of the healthcare vernacular, we worked tirelessly to educate the healthcare industry – providers, payers, life sciences companies, regulators, and even patients, of the need to support the development, use, and application of the evidence generated from real-world research.
Now the understanding of the need for real-world evidence within the scientific and medical community is firmly rooted. The collaborative nature of our relationships and our work with other organizations interested in solving these evidentiary challenges has allowed us to break down silos that exist within our US healthcare delivery system and accomplish a great deal of work. We’ve reached across tables and stakeholder lines to help inform and improve policies, programs, guidelines, best practices, and more for decision makers and patients.
Today we have nearly three decades of experience supporting this need with a powerful ecosystem of expertise, data, and relationships. Our ability to measure and help improve the safety, effectiveness, and affordability of medical technologies is critical to solving healthcare’s most complex challenges.
Mark Cziraky, PharmD, CLS
Mark Cziraky, PharmD, CLS is co-founder and President of Carelon Research (formerly HealthCore). Mark has been extensively involved in healthcare research for more than 25 years. Mark’s experience spans leadership roles in clinical pharmacy practice with a focus on cardiovascular risk management, academics, clinical trial management, health policy, and retrospective and prospective observational research design and conduct. As leader of Carelon Research, Mark serves as a key architect in creating open-source research collaborations within the healthcare industry.
Follow Carelon Research on LinkedIn to see how our leaders are solving today’s most complex health challenges.
